Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Allen C, Barber RM. A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–548.27918777
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.25220842
   PubMed Web of Science ®Google Scholar
• McGuire S. World Cancer Report 2014. Vol. 2015 Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press; 2016.
   Google Scholar
• World Health Organization. Latest Global Cancer Data: Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Cancer Deaths in 2018. International Agency for Research on Cancer. Geneva: World Health Organization; 2018.
   Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Remark R, Becker C, Gomez JE, et al. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med. 2015;191(4):377–390.25369536
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.25822800
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang E, Long J, et al. Immune infiltration in renal cell carcinoma. Cancer Sci. 2019;110(5):1564–1572.30861269
   PubMed Web of Science ®Google Scholar
• Zhou R, Zhang J, Zeng D, et al. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer. Cancer Immunol Immunother. 2019;68(3):433–442. doi:10.1007/s00262-018-2289-730564892
   PubMed Web of Science ®Google Scholar
• McDonald KA, Kawaguchi T, Qi Q, et al. Tumor heterogeneity correlates with less immune response and worse survival in breast cancer patients. Ann Surg Oncol. 2019;26(7):2191–2199. doi:10.1245/s10434-019-07338-330963401
   PubMed Web of Science ®Google Scholar
• Sato Y, Yoshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013;45(8):860. doi:10.1038/ng.269923797736
   PubMed Web of Science ®Google Scholar
• Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559.28555670
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Al-Shibli K, Donnem T, et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thor Oncol. 2011;6(4):824–833.
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110.29092952
   PubMed Web of Science ®Google Scholar
• Dadabayev R, Sandel MH, Menon AG, et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother. 2004 53;11:978–986.15197496
   PubMed Web of Science ®Google Scholar
• Atreya I, Neurath MF. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Rev Anticancer Ther. 2008 8(4):561–572.18402523
   PubMed Web of Science ®Google Scholar
• Wu Y, Yuan L, Lu Q, et al. Distinctive profiles of tumor-infiltrating immune cells and association with intensity of infiltration in colorectal cancer. Oncol Lett. 2018;15(3):3876–3882.29456737
   PubMed Web of Science ®Google Scholar
• Naito Y, Saito K, Shiiba K, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58(16):3491–3494.9721846
   PubMed Web of Science ®Google Scholar
• Hestdal K, Aukrust P, Müller F, et al. Dysregulation of membrane-bound tumor necrosis factor-α and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus Type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advance. 1997;90(7):2670–2679.
   Google Scholar
• Endo S, Inada K, Wakabayashi G, et al. Tumor Necrosis Factor-a and Tumor Necrosis Factor Receptor I, II Levels in Patients with Severe Burns. Circulation. 2000;26(3):239–244.
   Google Scholar
• Stanilov NS, Dobreva ZG, Stanilova SA. Higher TNF-alpha production detected in colorectal cancer patients monocytes. Biotechnol Biotechnol Equip. 2012;26(sup1):107–110.
   Web of Science ®Google Scholar
• Kaler P, Godasi BN, Augenlicht L, et al. The NF-κB/AKT-dependent induction of wnt signaling in colon cancer cells by macrophages and IL-1β. Cancer Microenviron. 2009;2(1):69–80.19779850
   PubMedGoogle Scholar
• Gao L, Zhou Y, Zhou SX, et al. PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells. Oncol Rep. 2016.
   Web of Science ®Google Scholar
• Kehoe J, Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am. 15(1):129–146.16389154
   PubMed Web of Science ®Google Scholar
• Zeestraten ECM, Reimers MS, Saadatmand S, et al. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer. 2014;110(2):459–468.24196788
   PubMed Web of Science ®Google Scholar
• West NP, Morris `EJA, Rotimi O, et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9(9):857–865.18667357
   PubMed Web of Science ®Google Scholar
• Missiaglia E, Jacobs B, D’ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25(10):1995–2001.25057166
   PubMed Web of Science ®Google Scholar
• Yongfu X, Kang W, He Z, et al. Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study. Cancer Med. 2018.
   Web of Science ®Google Scholar
• Ge P, Wang W, Li L, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. Biomed Pharmacother. 2019;109228.31351430
   PubMed Web of Science ®Google Scholar